Delivery Order SPE2DR25D9628-SPE2DR26FBSZZ
- Not listed
- The U.S. Defense Logistics Agency issued a firm fixed-price delivery order valued at $2,108.97 to DMS Pharmaceutical Group Inc. for TICOVAC 2.4 micrograms/0.5 milliliter vaccine in a 10-dose configuration. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded this delivery order on July 31, 2025, with an ultimate completion date of August 18, 2025. The contract carries no set-aside designation, and performance will take...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $6,326.91 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for TICOVAC 2.4 MCG/0.5 vaccine product. The delivery order, issued on October 23, 2025, with an ultimate completion date of November 6, 2025, was structured as a firm fixed-price contract with no set-aside designation, allowing the vendor to compete on equal...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $1,260.36 for TICOVAC 1.2 MCG/0.25 1S vaccine product by the Medical Supply Chain division of the Defense Logistics Agency. This firm fixed-price delivery order, awarded on June 6, 2025, with an ultimate completion date of June 6, 2025, carries no set-aside designation. The award leverages DMS Pharmaceutical Group's position as a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,261.86 for TICOVAC 2.4MCG/.5ML vaccine by the Defense Logistics Agency's Medical Supply Chain on July 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 7, 2025, carries no set-aside designation and will be performed at the contractor's Park Ridge facility. The award represents a single delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $9,111.20 for TICOVAC 1.2MCG/0.25 1S on July 18, 2025. This firm fixed-price delivery order was issued without a set-aside designation and is being fulfilled at the company's Park Ridge location. The award is funded by the Defense Logistics Agency's Medical Supply Chain division, reflecting the agency's ongoing procurement of pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $4,201.20 for TICOVAC 1.2 milligram/0.25 milliliter vaccines. This firm fixed-price delivery order, issued on August 13, 2025, with an ultimate completion date of August 13, 2025, represents a single issuance under the company's larger Indefinite Delivery Contract with the Defense Logistics Agency. The contract contains no set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,680.48 for TICOVAC 1.2MCG/0.25 1S by the Defense Logistics Agency's Medical Supply Chain office. The award, issued on July 18, 2025, with an ultimate completion date of the same day, represents a discrete order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at approximately $500...
- The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain program, awarded a firm fixed-price delivery order valued at $2,851.32 to DMS Pharmaceutical Group Inc. for TICOVAC 1.2MCG/0.25 1S vaccine supply. The award, issued on August 4, 2025, with an ultimate completion date of the same day, does not utilize a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the delivery...
- The U.S. Department of Defense Medical Supply Chain awarded a firm fixed-price delivery order valued at $1,050.30 to DMS Pharmaceutical Group Inc. for TICOVAC 1.2 micrograms per 0.25 milliliter vaccine product. The award, issued on May 2, 2025, with an ultimate completion date of May 5, 2025, represents a standard procurement action with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform...
- This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $82,528 firm fixed-price contract is for the delivery of TICOVAC 2.4MCG/0.5 10S, a pharmaceutical product, with a completion date of August 2, 2022. DMS Pharmaceutical Group holds a significant $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- SPE2DR25D9628Indefinite Delivery Contract
- SPE2DR25D9628-SPE2DR26FBSZZDelivery Order
The Defense Logistics Agency issued a firm fixed-price delivery order valued at $1,260.48 to DMS Pharmaceutical Group Inc. for TICOVAC 1.2MCG/0.25 1S on October 23, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded this delivery order without a set-aside designation, demonstrating its competitive capability in unrestricted federal procurement. The delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a comprehensive $30.3 billion acquisition strategy designed to supply pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with substantial contracting activity through the Defense Logistics Agency's Medical Supply Chain division. The company's product portfolio encompasses branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables. The underlying IDC, designated SPE2DR and awarded November 13, 2025, carries a ceiling value of $499,999,999 with a completion date of December 31, 2036, consisting of a 30-month base period and three 30-month option periods. This delivery order represents one of numerous firm fixed-price orders issued to the company to support recurring medical supply needs across the military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 10/23/25 |